Cargando…

Pulmonary impairment after tuberculosis and its contribution to TB burden

BACKGROUND: The health impacts of pulmonary impairment after tuberculosis (TB) treatment have not been included in assessments of TB burden. Therefore, previous global and national TB burden estimates do not reflect the full consequences of surviving TB. We assessed the burden of TB including pulmon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasipanodya, Jotam G, McNabb, Scott JN, Hilsenrath, Peter, Bae, Sejong, Lykens, Kristine, Vecino, Edgar, Munguia, Guadalupe, Miller, Thaddeus L, Drewyer, Gerry, Weis, Stephen E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894771/ https://www.ncbi.nlm.nih.gov/pubmed/20482835 http://dx.doi.org/10.1186/1471-2458-10-259

Ejemplares similares

Non-hispanic whites have higher risk for pulmonary impairment from pulmonary tuberculosis
por: Pasipanodya, Jotam G, et al.
Publicado: (2012)

Personal and Societal Health Quality Lost to Tuberculosis
por: Miller, Thaddeus L., et al.
Publicado: (2009)

Measuring health-related quality of life in tuberculosis: a systemic review - Response
por: Weis, Stephen E, et al.
Publicado: (2010)

Differences in risk factors for children with special health care needs (CSHCN) receiving needed specialty care by socioeconomic status
por: Lykens, Kristine A, et al.
Publicado: (2009)

Comprehensive effective and efficient global public health surveillance
por: McNabb, Scott JN
Publicado: (2010)

A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients
por: Pasipanodya, Jotam G., et al.
Publicado: (2013)

Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse
por: Magombedze, Gesham, et al.
Publicado: (2021)

Therapy duration and long-term outcomes in extra-pulmonary tuberculosis
por: Pusch, Tobias, et al.
Publicado: (2014)

Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients
por: Pasipanodya, Jotam G.
Publicado: (2021)

Evaluation of tuberculosis public health surveillance, Al-Madinah province, Kingdom of Saudi Arabia, 2012
por: Alkhalawi, Mohammed J., et al.
Publicado: (2016)

Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
por: Deshpande, Devyani, et al.
Publicado: (2022)

The Continued Threat of Tuberculosis
por: Navin, Tom, et al.
Publicado: (2002)

Distribution and determinants of tuberculosis in the Kingdom of Saudi Arabia from 2005 to 2012
por: Almutairi, Fahad M., et al.
Publicado: (2018)

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks
por: Srivastava, Shashikant, et al.
Publicado: (2016)

Overview of the design and development of public health case studies
por: Farhat, Ghada N, et al.
Publicado: (2017)

African Case Studies for Public Health Volume 2
por: Farhat, Ghada N, et al.
Publicado: (2018)

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo
por: Deshpande, Devyani, et al.
Publicado: (2016)

Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2015)

Does directly observed therapy (DOT) reduce drug resistant tuberculosis?
por: Moonan, Patrick K, et al.
Publicado: (2011)

HIV, Sexually Transmitted Diseases, Tuberculosis, and Malaria: Resurgence and Response
por: Holmberg, Scott, et al.
Publicado: (2004)

Disease surveillance, capacity building and implementation of the International Health Regulations (IHR[2005])
por: Katz, Rebecca L, et al.
Publicado: (2010)

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
por: Deshpande, Devyani, et al.
Publicado: (2016)

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2016)

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way
por: Deshpande, Devyani, et al.
Publicado: (2016)

Evaluation of home respiratory therapy delivered to patients in the Ministry of Health’s Home Medical Program (HMP) and administered through the Madinah HMP Center, Kingdom of Saudi Arabia, 2013
por: Alhelali, Rana A., et al.
Publicado: (2016)

Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality
por: Pasipanodya, Jotam G., et al.
Publicado: (2015)

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground
por: Srivastava, Shashikant, et al.
Publicado: (2016)

Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis
por: Deshpande, Devyani, et al.
Publicado: (2018)

Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development
por: Gumbo, Tawanda, et al.
Publicado: (2023)

Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis
por: Sibandze, Doctor B., et al.
Publicado: (2020)

Commentary for Special Issue “Public health is new in Saudi Arabia. With this degree, I can go back and help to develop the field there.” – Naif Mohammed Alraihan, King Abdullah Fellow, Rollins School of Public Health, 2015
por: McNabb, Scott J.N., et al.
Publicado: (2016)

Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2016)

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis
por: Rockwood, Neesha, et al.
Publicado: (2017)

Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB
por: Churchyard, Gavin J., et al.
Publicado: (2019)

DNA Fingerprinting of Mycobacterium tuberculosis: Lessons Learned and Implications for the Future
por: McNabb, Scott J. N., et al.
Publicado: (2002)

Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2017)

Molecular characterization and antimicrobial susceptibility of  extended-spectrum b-lactamases (ESBL) producing enterobactericiaceae (ESBLPE) causing urinary tract infections (UTI): Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010–2015, South Africa
por: Magazi, Beki Temba, et al.
Publicado: (2017)

Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments
por: Liu, Yongge, et al.
Publicado: (2023)

Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004–2012
por: Aloufi, Abdulaziz D., et al.
Publicado: (2016)

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
por: Swaminathan, Soumya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_le48qid85svt1m49bsgb74ve3g